Hims & Hers prices $870M 0.00% convertible notes due 2030 for global expansion and AI investment

Hims & Hers Health, Inc.

Initial $450M offering upsized to $870M; initial purchasers option for additional $130M.
Zero-coupon notes due 2030; initial conversion price ~$70.67/share (37.5% premium over $51.40 close).
Net proceeds est. $842.7M ($968.8M if full exercise); ~$41.6M for capped call transactions.
Proceeds for global expansion (organic + M&A), AI/data platform; no material acquisition agreements yet.
New CTO Mo Elshenawy leading tech team to develop AI tools and personalized treatments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.